India test-fires new surface-to-air missile co-developed with Israel
India on Thursday successfully test fired a new surface-to-air missile, developed jointly with Israel, from a defence base off Odisha coast.
The medium range missile (MR-SAM), a product of joint venture between India and Israel, was successfully test launched from a mobile launcher in the Integrated Test Range (ITR) at Chandipur at around 08.15 hours, a DRDO official said.
“The test launch was a grand success and it met all the targets,” he said.
The missile positioned at launch pad-3 of the ITR swung in to action after getting signal from the radars to intercept a moving aerial target supported by an unmanned air vehicle (UAV) ‘Banshee’ over the Bay of Bengal, officials said.
Apart from the missile, the system includes a Multi Functional Surveillance and Threat Alert Radar (MF STAR) for detection, tracking and guidance of the missile, they said.
“The missile along with MF-STAR will provide the users with the capability to neutralise any aerial threats,” said a Defence Research & Development Organisation (DRDO) scientist.
Indian Defence Research Development Laboratory (DRDL), a laboratory of DRDO based at Hyderabad, has jointly developed this missile in collaboration with Israel Aerospace Industries (IAI), he said.
A new production facility to deliver 100 missiles a year has been established for such type of long rang and medium range surface-to-air missiles at M/s Bharat Dynamics Limited, India.
The missile, which was initially proposed to be tested yesterday, was deferred in the last moment for today.
Earlier, Indian Navy had successfully test launched the long range surface-to-air missile (LR-SAM). The test was undertaken on the Western Seaboard by INS Kolkata on December 30, 2015, officials said.
Such type of medium range surface-to-air missiles (SR-SAM), having striking ranges from 50 to 70 km, can fill the gap of existing missiles that India has in its armory at present, they said.
These missiles would be inducted in all three services after user’s trial is completed.